Your browser doesn't support javascript.
loading
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.
Hu, Bomiao; Wiesehöfer, Marc; de Miguel, Fernando J; Liu, Zongzhi; Chan, Lok-Hei; Choi, Jungmin; Melnick, Mary Ann; Arnal Estape, Anna; Walther, Zenta; Zhao, Dejian; Lopez-Giraldez, Francesc; Wurtz, Anna; Cai, Guoping; Fan, Rong; Gettinger, Scott; Xiao, Andrew; Yan, Qin; Homer, Robert; Nguyen, Don X; Politi, Katerina.
Afiliação
  • Hu B; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Wiesehöfer M; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • de Miguel FJ; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • Liu Z; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Chan LH; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Choi J; Department of Genetics, Yale School of Medicine, New Haven, Connecticut.
  • Melnick MA; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • Arnal Estape A; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Walther Z; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • Zhao D; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Lopez-Giraldez F; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • Wurtz A; Department of Genetics, Yale School of Medicine, New Haven, Connecticut.
  • Cai G; Yale Center for Genome Analysis (YCGA) Yale School of Medicine, New Haven, Connecticut.
  • Fan R; Department of Genetics, Yale School of Medicine, New Haven, Connecticut.
  • Gettinger S; Yale Center for Genome Analysis (YCGA) Yale School of Medicine, New Haven, Connecticut.
  • Xiao A; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • Yan Q; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Homer R; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.
  • Nguyen DX; Department of Biomedical Engineering, Yale School of Engineering and Applied Science, New Haven, Connecticut.
  • Politi K; Department of Medicine (Section of Medical Oncology), Yale School of Medicine, New Haven, Connecticut.
Cancer Res ; 84(8): 1303-1319, 2024 04 15.
Article em En | MEDLINE | ID: mdl-38359163

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Acrilamidas / Carcinoma Pulmonar de Células não Pequenas / Indóis / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Acrilamidas / Carcinoma Pulmonar de Células não Pequenas / Indóis / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Res Ano de publicação: 2024 Tipo de documento: Article